Literature DB >> 28722469

Recent advances in gossypol derivatives and analogs: a chemistry and biology view.

Yuzhi Lu1, Jun Li1, Chun-E Dong1, Jian Huang2, Hai-Bing Zhou1, Wei Wang1.   

Abstract

Gossypol as a natural occurring polyphenol has been studied in a wide range of therapeutic contexts for a long time. The chemical modifications on gossypol were limited due to the unique chemical properties of polyphenols. The design and synthesis of gossypol derivatives and the exploration of their biological activities are the interest of the synthetic chemists, medicinal chemists and pharmacologists. Thus, the progress of diverse gossypol derivatives and analogs' synthesis, biological activities, mechanism elucidation and drug discovery based on gossypol scaffold is summarized.

Entities:  

Keywords:  Bcl-2 inhibitor; antiapoptotic; antitumor; gossypol; gossypol derivatives; natural product chemistry; polyphenols; scaffold hopping; structure–activity relationship; synthetic chemistry

Mesh:

Substances:

Year:  2017        PMID: 28722469     DOI: 10.4155/fmc-2017-0046

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  10 in total

1.  Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model.

Authors:  Vivian Adamski; Christina Schmitt; Florian Ceynowa; Rainer Adelung; Ralph Lucius; Michael Synowitz; Kirsten Hattermann; Janka Held-Feindt
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-01       Impact factor: 4.553

2.  Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells.

Authors:  Moiken Mehner; Carolin Kubelt; Vivian Adamski; Christina Schmitt; Michael Synowitz; Janka Held-Feindt
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-16       Impact factor: 4.553

3.  Practical Strategy to 1,1'-Dideoxygossypol Derivatives from Gossypol and Its Antitumor Activities.

Authors:  Wei Wang; Yuzhi Lu; Juncheng Ge; Niya Liu
Journal:  ACS Omega       Date:  2022-06-22

4.  A randomized, double-blind, placebo-controlled study of B-cell lymphoma 2 homology 3 mimetic gossypol combined with docetaxel and cisplatin for advanced non-small cell lung cancer with high expression of apurinic/apyrimidinic endonuclease 1.

Authors:  Yuxiao Wang; Xuemei Li; Liang Zhang; Mengxia Li; Nan Dai; Hao Luo; Jinlu Shan; Xueqin Yang; Mingfang Xu; Yan Feng; Chengxiong Xu; Chengyuan Qian; Dong Wang
Journal:  Invest New Drugs       Date:  2020-06-11       Impact factor: 3.850

5.  Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?

Authors:  Qing Yu; Yi Sun
Journal:  Drug Des Devel Ther       Date:  2021-01-06       Impact factor: 4.162

6.  AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.

Authors:  Dorota K Flak; Vivian Adamski; Grzegorz Nowaczyk; Kosma Szutkowski; Michael Synowitz; Stefan Jurga; Janka Held-Feindt
Journal:  Int J Nanomedicine       Date:  2020-10-05

Review 7.  PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.

Authors:  Lennox Chitsike; Penelope J Duerksen-Hughes
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

8.  Investigation of Inhibition Effect of Gossypol-Acetic Acid on Gastric Cancer Cells Based on a Network Pharmacology Approach and Experimental Validation.

Authors:  Youqiang Liu; Yanlin Ma; Zheng Li; Yang Yang; Bin Yu; Zhenya Zhang; Guiying Wang
Journal:  Drug Des Devel Ther       Date:  2020-09-07       Impact factor: 4.162

9.  Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes.

Authors:  Qing Yu; Zhiguo Hu; Yanwen Shen; Yihan Jiang; Peichen Pan; Tingjun Hou; Zhen-Qiang Pan; Jing Huang; Yi Sun
Journal:  Neoplasia       Date:  2020-04       Impact factor: 5.715

10.  Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche.

Authors:  Deniz Caylioglu; Rieke Johanna Meyer; Dana Hellmold; Carolin Kubelt; Michael Synowitz; Janka Held-Feindt
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.